Sweeteners
fructose worsens appetite
Part of: • fructose
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
How the studies fall
What the evidence shows
Unlike glucose, fructose does not robustly stimulate insulin and leptin or suppress ghrelin, so it produces a weaker satiety signal — a plausible route by which fructose-rich foods/drinks promote overconsumption. Human evidence supports the differential hormonal response; whether it translates into meaningfully higher long-term intake is less certain.
The evidence (5)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Flores Monar GV et al 2025 · Journal of Nutrition and Metabolism | mechanism | supports | low | Narrative review (J Nutr Metab 2025), no data of its own - 'This publication does not present new data. All information included has been sourced from previously published articles and is appropriately referenced.' On this claim it restates the mechanistic case: fructose 'only weakly impacts the circulating levels of insulin', 'decreases glucagon-like peptide 1 (GLP-1)24, a satiety hormone, and does not attenuate increasing levels of the appetite-stimulating hormone ghrelin', so that 'The limited ability of fructose to stimulate satiety hormones like leptin and insulin results in AMPK activation and minimally excites POMC neurons while keeping NPY/AgRP neuron signals active, leading to lower satiety than glucose and consequently more food intake.' Direction supports; weight belongs to the primary studies it cites, not to this review. |
| Jung et al. 2022 · Annu Rev Nutr | observational | mixed | moderate | Narrative review (Annu Rev Nutr), abstract only — no full text obtainable. The abstract's stated scope is fructose metabolism 'in different organs and gut microbiota' and 'the role of fructose in the pathogenesis of metabolic diseases'; appetite, satiety, ghrelin and leptin are not mentioned in the readable text, so whether this review addresses the claim's outcome cannot be told. Reports no new data. Zero-weighted as evidence_role: review. |
| Stanhope 2009 · J Clin Invest 2009 May;119(5):1322-1334 | RCT | supports | high | RCT: fructose vs glucose produced lower insulin and leptin responses — the weaker satiety-hormone signal. |
| Jensen et al. 2018 · J Hepatol 2018 May;68(5):1063-1075 | observational | supports | low | OFF-SCOPE for an appetite/satiety claim. The review's declared scope is hepatic: 'Herein, we review the experimental and clinical evidence that fructose precipitates fat accumulation in the liver, due to both increased lipogenesis and impaired fat oxidation.' Appetite, satiety, insulin/leptin signalling and ghrelin appear nowhere in the available text; the mechanisms it does advance are fructokinase C / uric acid - 'Recent evidence suggests that the predisposition to fatty liver is linked to the metabolism of fructose by fructokinase C, which results in ATP consumption, nucleotide turnover and uric acid generation that mediate fat accumulation.' - and the gut barrier - 'Alterations to gut permeability, the microbiome, and associated endotoxemia contribute to the risk of NAFLD and NASH.' The prior extract ('fructose bypasses key satiety signaling (insulin/leptin), favoring positive energy balance') is not attributable to this paper on the text available; it reads as an assumed-mechanism gloss, not a restatement of anything the review says. Abstract-only; full text not obtainable (Europe PMC 0 bytes for PMC5893377). |
| Matsui T et al 2026 · bioRxiv | RCT | supports | low | bioRxiv PREPRINT (not peer-reviewed): randomized double-blind crossover, n=11 healthy young men, esports sessions; two gels matched for energy and total carbohydrate (HFCS-dominant vs maltodextrin-dominant). Vs the MDX gel, the HFCS-dominant condition showed lower late-phase interstitial glucose, progressively HIGHER hunger and higher cortisol; MDX also preserved executive control. Supports fructose-heavier carbohydrate worsening the hunger trajectory, but the study is designed around the MDX formulation (possible sponsor framing; funding not stated in abstract), tiny n, gaming context. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.